#fda-orphan-drug
#fda-orphan-drug

[ follow ]

#biotechnology #blood-stem-cells #cancer-treatment #rejuvenation-therapy

HexemBio raises $10.4M for a stem cell rejuvenation therapy

HexemBio develops a blood stem cell rejuvenation therapy using a recreated embryonic environment, targeting bone marrow transplants for blood cancers.

[ Load more ]

#fda-orphan-drug#fda-orphan-drug

HexemBio raises $10.4M for a stem cell rejuvenation therapy

#fda-orphan-drug
#fda-orphan-drug